Portal:CPTAC/Hallmark/Therapeutics

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
(adding cancer immunotherapy pathways)
Current revision (21:37, 10 October 2019) (view source)
(added irinotecan)
 
(3 intermediate revisions not shown.)
Line 10: Line 10:
*[[Pathway:WP3844]] PI3K-AKT-mTOR signaling pathway and therapeutic opportunities
*[[Pathway:WP3844]] PI3K-AKT-mTOR signaling pathway and therapeutic opportunities
*[[Pathway:WP3593]] MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma
*[[Pathway:WP3593]] MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma
-
*[[Pathway:WP4585]] Cancer immunotherapy by PD1 blockade
+
*[[Pathway:WP4585]] Cancer immunotherapy by PD-1 blockade
*[[Pathway:WP4582]] Cancer immunotherapy by CTLA4 blockade
*[[Pathway:WP4582]] Cancer immunotherapy by CTLA4 blockade
 +
*[[Pathway:WP4559]] Interactions between immune cells and microRNAs in tumor microenvironment
 +
*[[Pathway:WP4560]] MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement
 +
*[[Pathway:WP229]] Irinotecan Pathway

Current revision

Personal tools